{
  "trial_id": "NCT02776202",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "met",
      "evidence": "35-year-old woman"
    },
    {
      "criterion": "Myasthenia Gravis",
      "label": "met",
      "evidence": "class IIa, positive anti-AChR antibody test, single fiber electromyography (SFEMG) was positive"
    }
  ],
  "exclusion": [
    {
      "criterion": "GVHD prophylaxis",
      "label": "triggers",
      "evidence": "used as GVHD prophylaxis and to prevent graft rejection"
    },
    {
      "criterion": "Cirrhosis on liver biopsy",
      "label": "triggers",
      "evidence": "cirrhosis on liver biopsy"
    }
  ],
  "notes": "Patient has myasthenia gravis, class IIa. She complains of diplopia and fatigue and weakness that affects mainly her upper limbs.",
  "_meta": {
    "topic_id": "38",
    "trial_id": "NCT02776202",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}